OTS-964 | Interleukin Related interleukin-related.com

Product Name :
OTS-964

Search keywords :
OTS964

drugId :
null

Target Vo:
T LAK cell originated protein kinase

Target Vo Short Name :
TOPK

Moa_Name:
T LAK cell originated protein kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Oncotherapy Science, Inc

Active Company_Name :
Oncotherapy Science, Inc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IRF3 Antibody
His Tag Antibody (HRP) (YA877)
E2F1 Antibody: E2F1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to E2F1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts